Palmoplantar Psoriasis: Epidemiological and Clinical Features and Impact on Quality of Life
Introduction: Palmoplantar psoriasis is a rare variant of psoriasis. Its impact on quality of life have been poorly investigated. Objectives: Our aim was to investigate the prevalence of localized palmoplantar psoriasis (PPP), to assess its severity using the modified-Palmoplantar Pustular Psoriasis...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Book |
Published: |
Mattioli1885,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_017dd9907e204e96a45df8acf006a7b5 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Dorsaf Elinkichari |e author |
700 | 1 | 0 | |a Faten Rabhi |e author |
700 | 1 | 0 | |a Kahena Jaber |e author |
700 | 1 | 0 | |a Raouf Dhaoui |e author |
245 | 0 | 0 | |a Palmoplantar Psoriasis: Epidemiological and Clinical Features and Impact on Quality of Life |
260 | |b Mattioli1885, |c 2024-07-01T00:00:00Z. | ||
500 | |a 10.5826/dpc.1403a191 | ||
500 | |a 2160-9381 | ||
520 | |a Introduction: Palmoplantar psoriasis is a rare variant of psoriasis. Its impact on quality of life have been poorly investigated. Objectives: Our aim was to investigate the prevalence of localized palmoplantar psoriasis (PPP), to assess its severity using the modified-Palmoplantar Pustular Psoriasis Area and Severity Index (m-PPPASI), and to evaluate the correlation with the Dermatology Life Quality Index (DLQI). Methods: We conducted a descriptive study with prospective data-collection from January to June 2021. We enrolled 223 patients with psoriasis. We excluded patients without palmar/plantar involvement, and those with a body surface area (BSA) greater than or equal to 10%. Results: We included 33 patients with PPP. This corresponded to a 14.8% prevalence among all psoriasis phenotypes. The mean age was 45 years. The male to female ratio was 2.3. Pruritus was present in 27 cases. The mean m-PPPASI was 11.77. The mean DLQI was 8.33. A significant correlation was found between DLQI and m-PPPASI: Mean DLQI scores for patients with m-PPPASI less than or equal to 10 and m-PPPASI greater than 10 were 5.6 and 11.3, respectively (p=0.002). Only 11.8% of patients with m-PPPASI less than or equal to 10 had a DLQI greater than 10, whereas 50% of those with m-PPPASI greater than 10 had a DLQI greater than 10 (p=0.026). Conclusions: Based on the present work, we confirm that, although affecting a reduced BSA, PPP is a severe form of psoriasis. We consider the m-PPPASI to be a reliable tool which can be used to assess the severity of PPP. | ||
546 | |a EN | ||
690 | |a Psoriasis | ||
690 | |a Palmoplantar Psoriasis | ||
690 | |a Keratoderma | ||
690 | |a Quality of life | ||
690 | |a Dermatology | ||
690 | |a RL1-803 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Dermatology Practical & Conceptual, Vol 14, Iss 3 (2024) | |
787 | 0 | |n https://dpcj.org/index.php/dpc/article/view/2754 | |
787 | 0 | |n https://doaj.org/toc/2160-9381 | |
856 | 4 | 1 | |u https://doaj.org/article/017dd9907e204e96a45df8acf006a7b5 |z Connect to this object online. |